CoreCap Advisors’s Medical Properties Trust MPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$36.1K Sell
7,811
-800
-9% -$3.96K ﹤0.01% 1556
2026
Q1
$39.9K Sell
8,611
-362
-4% -$1.89K ﹤0.01% 1398
2025
Q4
$44.9K Buy
8,973
+8,550
+2,021% +$44.5K ﹤0.01% 1382
2025
Q3
$2.15K Hold
423
﹤0.01% 2368
2025
Q2
$1.82K Sell
423
-2,356
-85% -$11.6K ﹤0.01% 2322
2025
Q1
$16.8K Buy
2,779
+2,222
+399% +$11.2K ﹤0.01% 1616
2024
Q4
$2.2K Sell
557
-680
-55% -$3.05K ﹤0.01% 2198
2024
Q3
$7.24K Sell
1,237
-15,120
-92% -$74.5K ﹤0.01% 1879
2024
Q2
$70.5K Sell
16,357
-257
-2% -$1.23K 0.01% 577
2024
Q1
$78.1K Buy
+16,614
New +$63.6K ﹤0.01% 946
2022
Q4
$142K Buy
12,737
+1,200
+10% +$14K 0.01% 616
2022
Q3
$137K Buy
11,537
+2,000
+21% +$30.3K 0.01% 508
2022
Q2
$146K Buy
+9,537
New +$172K 0.01% 585
2022
Q1
Sell
-6,758
Closed -$160K 1474
2021
Q4
$160K Buy
+6,758
New +$145K 0.01% 593

Other funds holding MPT

CoreCap Advisors's MPT Position: Q2 2026 in Review

CoreCap Advisors reduced its Medical Properties Trust (MPT) stake by 9.3% in Q2 2026, selling an estimated $3.96K and leaving 7,811 shares worth $36.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1556.

CoreCap Advisors first reported a position in MPT in Q4 2021 and has held it in 14 quarters since. The position peaked at $160K in Q4 2021. 77 funds tracked by Wall St. Rank hold MPT as of Q2 2026.

  • CoreCap Advisors held 7,811 shares of Medical Properties Trust worth $36.1K as of Q2 2026.
  • CoreCap Advisors sold 800 Medical Properties Trust shares in Q2 2026, an estimated $3.96K.
  • Medical Properties Trust made up ﹤0.01% of CoreCap Advisors's portfolio in Q2 2026, its #1556 holding.
  • CoreCap Advisors first reported a position in Medical Properties Trust in Q4 2021 and has held it in 14 quarters since.
  • CoreCap Advisors's Medical Properties Trust position peaked at $160K in Q4 2021.
  • 77 funds tracked by Wall St. Rank held Medical Properties Trust as of Q2 2026.

Based on CoreCap Advisors's 13F filing for Q2 2026, filed 6 Jul 2026.